Terms: = Brain cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808 AND Diagnosis
4 results:
1. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
[TBL] [Abstract] [Full Text] [Related]
2. A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall.
Broggi G; Mazzucchelli M; Covello R; Casini B; Barbagallo GMV; Salvatorelli L; Magro G
Pathol Res Pract; 2022 Apr; 232():153803. PubMed ID: 35217266
[TBL] [Abstract] [Full Text] [Related]
3. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
[TBL] [Abstract] [Full Text] [Related]
4. Primary CNS Alveolar Rhabdomyosarcoma: Importance of Epigenetic and Transcriptomic Assays for Accurate diagnosis.
Jour G; Serrano J; Koelsche C; Jones DTW; von Deimling A; Allen J; Snuderl M
J Neuropathol Exp Neurol; 2019 Nov; 78(11):1073-1075. PubMed ID: 31553442
[TBL] [Abstract] [Full Text] [Related]
